Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2026 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| TARO-LISDEXAMFETAMINE CHEWABLE TABLETS | Taro Pharmaceuticals Inc | Marketed | Jun 4, 2024 | Marketed |
| SHEEN HYDRATING LIP BALM SPF 50 | GRACE & FIRE PTY LTD | Marketed | Jun 4, 2024 | Marketed |
| TEVA-LISDEXAMFETAMINE | teva canada limited | Marketed | Jun 3, 2024 | Marketed |
| TEVA-LISDEXAMFETAMINE | teva canada limited | Marketed | Jun 3, 2024 | Marketed |
| TEVA-LISDEXAMFETAMINE | teva canada limited | Marketed | Jun 3, 2024 | Marketed |
| TEVA-LISDEXAMFETAMINE | teva canada limited | Marketed | Jun 3, 2024 | Marketed |
| DRY COUGH RELIEF EXTRA STRENGTH | crls | Marketed | Jun 3, 2024 | Marketed |
| TEVA-LISDEXAMFETAMINE | teva canada limited | Marketed | Jun 3, 2024 | Marketed |
| ADTRALZA | LEO Pharma Inc | Marketed | Jun 3, 2024 | Marketed |
| TEVA-LISDEXAMFETAMINE | teva canada limited | Marketed | Jun 3, 2024 | Marketed |
| LEFLUNOMIDE | sivem pharmaceuticals ulc | Marketed | Jun 3, 2024 | Marketed |
| LEFLUNOMIDE | sivem pharmaceuticals ulc | Marketed | Jun 3, 2024 | Marketed |
| TEVA-LISDEXAMFETAMINE | teva canada limited | Marketed | Jun 3, 2024 | Marketed |
| AMB-BISACODYL | ambicare pharmaceuticals inc. | Marketed | Jun 3, 2024 | Marketed |
| DAILYSCREEN HYDRATING DAILY CREAM | supergoop, llc | Marketed | Jun 1, 2024 | Marketed |
| ESSENTIEL DISINFECTING WIPES LINGETTES DÉSINFECTANTES | ROCKLINE INDUSTRIES | Marketed | May 31, 2024 | Marketed |
| BACLOFEN | sivem pharmaceuticals ulc | Marketed | May 31, 2024 | Marketed |
| BACLOFEN | sivem pharmaceuticals ulc | Marketed | May 31, 2024 | Marketed |
| SANDOZ DESVENLAFAXINE | Sandoz Canada, Inc. | Marketed | May 30, 2024 | Marketed |
| SANDOZ DESVENLAFAXINE | Sandoz Canada, Inc. | Marketed | May 30, 2024 | Marketed |
